Skip to search.
 FTSE 100 Down 0.25%

AbbVie Inc. (ABBV)

-NYSE
68.22 Up 0.01(0.01%) 6 Jul 21:01
Add to Portfolio
Prev Close:68.21
Open:67.53
Bid:67.70 x 100
Ask:72.26 x 100
1y Target Est:74.00
Beta:1.63
Next Earnings Date:24-Jul-15ABBV Earnings announcement
Day's Range:67.49 - 69.00
52wk Range:51.37 - 70.76
Volume:17,029,081
Avg Vol (3m):10,949,100
Market Cap:108.68b
P/E (ttm):60.91
EPS (ttm):1.12
Div & Yield:2.04 (2.90%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.01%108.68b
MRKDown 0.21%162.59b
NVSDown 1.18%238.69b
PFEDown 0.36%204.74b

Key Statistics

Forward P/E (1 yr):13.64
P/S (ttm):5.32
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :4.24
Quarterly EPS Est (Jun-15) :1.05
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback